Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Türker Bilgen"'
Autor:
Alpay Yeşilaltay, Dilek Muz, Berna Erdal, Türker Bilgen, Bahadır Batar, Burhan Turgut, Birol Topçu, Bahar Yılmaz, Burcu Altındağ Avcı
Publikováno v:
Pathogens, Vol 13, Iss 1, p 72 (2024)
This study aimed to explore the effectiveness and safety of Myxoma virus (MYXV) in MM cell lines and primary myeloma cells obtained from patients with multiple myeloma. Myeloma cells were isolated from MM patients and cultured. MYXV, lenalidomide, an
Externí odkaz:
https://doaj.org/article/e3b28e26d82f4603ba4f970e7bddcb87
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 2, Pp 107-111 (2016)
INTRODUCTION: Although the calculated carrier frequency for point mutations of the β-globin gene is around 10% for Antalya Province, nothing is known about the profile of large deletional mutations involving the β-globin gene. In this study, we aim
Externí odkaz:
https://doaj.org/article/8b4aa288826c4489ab0cc4efc4a2b02c
Publikováno v:
Turkish Journal of Hematology, Vol 28, Iss 03, Pp 219-222 (2011)
Hemoglobin beta (HBB):c.*+96T>C substitution is very rare among β-globin gene mutations and its clinical significance remains to be clarified. The present study aimed to investigate the role of HBB:c.*+96T>C in the β-thalassemia intermedia phenotyp
Externí odkaz:
https://doaj.org/article/090a3a25b4164e56bf96d52ce744786b
Publikováno v:
Turkish Journal of Hematology, Vol 28, Iss 3, Pp 219-222 (2011)
Hemoglobin beta (HBB): c.*+96T>C substitution is very rare among β-globin gene mutations and its clinical significance remains to be clarified. The present study aimed to investigate the role of HBB: c.*+96T>C in the β-thalassemia intermedia phenot
Externí odkaz:
https://doaj.org/article/bc0eb29108cc4af08c7e5c8a0c5ca569
Publikováno v:
Balkan Journal of Medical Genetics, Vol 13, Iss 2, Pp 41-45 (2010)
Externí odkaz:
https://doaj.org/article/43179a5509b34971a875285fe0cce256
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 1, Pp 71-72 (2016)
Externí odkaz:
https://doaj.org/article/37007e5e831b476ab64c864296e99439
Publikováno v:
Turkish Journal of Hematology, Vol 32, Iss 4, Pp 374-375 (2015)
Externí odkaz:
https://doaj.org/article/fc58f11914f0468bacc9573282cea6c5
Autor:
Türker Bilgen, Mesut İzzet Titiz
Publikováno v:
Turkish Journal of Nephrology. 29:77-81
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c820510649594735bab7a4197d02be88
https://doi.org/10.5152/turkjnephrol.2020.3900
https://doi.org/10.5152/turkjnephrol.2020.3900
Autor:
Hande Akalan, Duygu Yaşar Şirin, Ipek Yılmaz, Pınar Ata, Veli Melih Kara, Nicel Taşdemir, Mesut Izzet Titiz, Türker Bilgen
Publikováno v:
Transplant immunology. 73
In addition to alloantibodies, alloreactive memory B cell (mBC) evaluation has a potential for immunological risk assessment during transplantation processes. For the alloreactive mBCs evaluation currently, direct Flow Cytometric (FC) analysis using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6fa245b7d32d3007508bae137d18ed
https://pubmed.ncbi.nlm.nih.gov/35667546
https://pubmed.ncbi.nlm.nih.gov/35667546
Publikováno v:
Transplantation proceedings. 51(4)
Cytotoxic flow cytometric crossmatch (cFCXM), identified by detecting complement-mediated cytotoxic cell death in addition to the capability of showing the alloantibodies binding onto lymphocytes at the same time, can reduce the necessary time and wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e774e5924aafb6ef3df93103460124bb
https://pubmed.ncbi.nlm.nih.gov/31101163
https://pubmed.ncbi.nlm.nih.gov/31101163